NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

The IFR (Individual Funding Request) pathway allows Murcidencel (DCVax-L) to be accessed on a case-by-case basis, but it’s important to recognize this as a strategic step rather than a full-funding decision. The HCD/IFR proves that NHS England validates DCVax-L's efficaciousness, safety, value— paving the way for broader NICE funding.

You have nothing... but carry on. We KNOW what we hold.